Answers are grounded in this paper and cite their sources.
Background: Autistic people may be at greater risk of developing alcohol and substance use disorders, despite being less likely to use drugs and alcohol overall. Little research has compared autistic and non-autistic adults across multiple drug classes in large international samples. This study aimed to examine patterns, reasons, and risks associated with drug use in autistic and non-autistic people, using survey data from the Global Drug Survey 2022. Methods: Logistic regression models were used to assess differences between autistic ( N = 725) and non-autistic participants ( N = 27,057) in odds of drug use, binge drinking, emergency medical treatment for drug and/or alcohol use, and reasons for use in past 12 months, and negative binomial regression with a log link function for frequency of drug use in days. Covariates in adjusted models were age, gender, ethnicity, and education. Correlations assessed relationships between frequency and impact of autism in daily life. Results: Autistic people had lower odds of using alcohol, cocaine, and cigarettes and greater odds of using prescription opioids compared with non-autistic people in the past 12 months. Of those who used each drug in the past 12 months, autistic respondents used alcohol significantly less frequently and amphetamine/crystal methamphetamine, cannabis, and cannabidiol (CBD) significantly more frequently than non-autistic people. Autistic respondents had greater odds of using cannabis for medical reasons and amphetamine for functional reasons and greater odds of seeking emergency medical treatment for alcohol and/or drug use compared with non-autistic people. There was no association between frequency of drug use and impact of autism. Conclusions: Despite lower odds of using alcohol and cigarettes, autistic people who used drugs did so more frequently for certain substances (amphetamine/methamphetamine, cannabis, and CBD), often for medical or functional reasons. These patterns suggest drug use may serve self-regulatory or coping functions, highlighting a need for tailored harm-reduction support.
No takes yet. Share an insight, caveat, or question.
Kerr‐Gaffney et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: